Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Melatonin for Glycemic Control in Gestational Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating melatonin for glycemic control in gestational diabetes mellitus, with status not yet recruiting. The study is sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Obstetrics & Gynecology Hospital of Fudan University | Conditions: Gestational Diabetes | Phase 2 | Status: NOT_YET_RECRUITING